Journal article
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
S Singh, L Moody, DL Chan, DC Metz, J Strosberg, T Asmis, DL Bailey, E Bergsland, K Brendtro, R Carroll, S Cleary, M Kim, G Kong, C Law, B Lawrence, A McEwan, C McGregor, M Michael, J Pasieka, N Pavlakis Show all
JAMA Oncology | AMER MEDICAL ASSOC | Published : 2018
Abstract
There is no consensus on optimal follow-up for completely resected gastroenteropancreatic neuroendocrine tumors. Published guidelines for follow-up are complex and emphasize closer surveillance in the first 3 years after resection. Neuroendocrine tumors have a different pattern and timescale of recurrence, and thus require more practical and tailored follow-up. The Commonwealth Neuroendocrine Tumour Collaboration convened an international multidisciplinary expert panel, in collaboration with the North American Neuroendocrine Tumor Society, to create patient-centered follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors. This panel used the RAND/UCLA (..
View full abstractGrants
Funding Acknowledgements
This project was funded by the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs).